In a large international multicenter real-life study, the dexamethasone intravitreal implant safely treated diabetic macular edema, with peak improvement at 3 months. Further information on treatment effects in early vs. late DME, naive vs. previously treated eyes and patients with controlled vs. non-controlled diabetes was also provided.
The study involved patients with DME and type 1 or type 2 diabetes from 25 clinical sites in eight countries in Europe and Israel. It evaluated the effects of the implant per injection as well as per series of injections with strict interval (Read more...)
Uncategorized